| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740709 | Journal of Infection and Chemotherapy | 2018 | 6 Pages |
Abstract
This study provides one plausible benchmark for appropriate antimicrobial therapy by ASP, while observer bias and survivor treatment selection bias exist, and further studies including evaluation for severity are needed.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mitsuru Yanai, Maiko Ogasawara, Yuta Hayashi, Kiyozumi Suzuki, Hiromichi Takahashi, Atsushi Satomura,